Home Lighting Tied to Activity Levels in Adults With Visual Impairment
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, Feb. 9, 2024 -- The home environment, particularly lighting, may influence home activity metrics in older adults with visual impairment, according to a study published online Feb. 8 in JAMA Ophthalmology.
Seema Banerjee, Ph.D., from Johns Hopkins University in Baltimore, and colleagues investigated the association between home environment features and home physical activity in patients with visual impairment. The analysis included 153 participants (60 years and older) with glaucoma suspect and primary glaucoma.
The researchers found that for every 0.1-log unit increment in average measured home lighting, participants tended to take more daily steps (rate ratio [RR], 1.05; 95 percent confidence interval [CI], 1.00 to 1.10) and had a faster average daily peak cadence (RR, 1.03; 95 percent CI, 1.01 to 1.05). Home lighting also showed trends with the average number of nonsedentary activity minutes (RR, 1.04; 95 percent CI, 1.00 to 1.07), average bout duration (β = 0.03), and activity fragmentation (β = −0.06). There were no associations seen between number of hazards and any activity metric (steps: RR, 1.14; 95 percent CI, 0.96 to 1.34; peak cadence: RR, 1.00; 95 percent CI, 0.93 to 1.08; and nonsedentary time: RR, 1.11; 95 percent CI, 0.98 to 1.26).
"Further prospective studies would be needed to confirm if home modifications can improve at-home activity," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-02-10 22:15
Read more
- Poll Finds Public Fears Over RSV Have Eased, Although It Remains a Threat
- Bird Flu Infection Confirmed in a Pig for First Time in U.S.
- ASN: Hypertension Most Common Cardiovascular Comorbidity Seen With Dialysis
- Election Fears Are Keeping Americans Awake at Night, Survey Shows
- Total Hip Replacement Revision Rates Vary With Type of Material Used
- In a National First, an Idaho Health Department Is Refusing to Give COVID Vaccines
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions